- email:professionalcustserv@informa.com
- phone:+44 (0) 20 7017 5503
 |
IBC Legal's 20th Annual
Biotech & Pharmaceutical Patenting Conference 2012
21 - 22 February 2012
|
The 20th Anniversary Biotech & Pharmaceutical Patenting Conference 2012: Protecting and developing international medical innovation and intellectual property
IBC Legal’s Biotech & Pharmaceutical Patenting 2012 event will help companies understand the complex and often subtle interplay in patenting and the regulatory framework upon which this sophisticated area is subject.
Expect to benefit from practical insights into how to develop patent strategies that maximise the lifecycles of patents whilst avoiding breaching antitrust laws.
Join our exceptional panel of speakers to discuss pharmaceuticals and biotech patent protection and competitive patent filing strategies, tactics and recent case law including (but not limited to) conclusions from:
- HGS v Lilly
- Ranbaxy v AstraZeneca
- Novartis AG v Johnson & Johnson
- Grimme v Scott
- KCI v Smith Nephew
- Brüstle v. Greenpeace
- Genericas UK (Mylan) v Novartis
-
Novartis v Actavis
-
Medeva
-
Georgetown University
Additionally, hear from industry experts on ways to minimise risk in pharmeceuticals.
Find out more and benefit from the best prices by downloading the latest agenda for the Biotech & Pharmaceutical Patenting conference 2012.
"Very well organised conference with particularly interesting content covering all 'hot' topics at present"
Past delegate, Pfizer
"All you need to know in biotech and pharma: annual update!"
Past Delegate, Cabinet Plasseraud
"A hugely useful update on issues right across the sector"
Past Delegate, Simmons & Simmons
"Excellent mix of discussion, panels and presentations. Very interesting topics"
Past Delegate, PMPS
Expert speakers at the 2012 Biotech & Pharma Patenting Conference:
Perspectives from your Colleagues and Regulators:
- Dieter Tzschoppe, Director Pharmaceuticals (Pure and Applied Organic Chemistry), European Patent Office
- David Ricol, , Senior Patent Attorney, European Patent
Attorney, Pfizer - Bernd Hutter, Director, Head of Intellectual Property,
European Patent Attorney, MorphoSys AG - Dr. Christof Bull, EPA, Associate General Patent Counsel, UCB Pharma SA
- Paul Wiegel, Senior Manager IP and US Patent Attorney,
MorphoSys AG - Susan Jones, Head Corporate Legal Antitrust, Novartis
International AG - Bernard McDonald, Global Intellectual Property Manager,
Emergent BioSolutions Inc.
Insights from Advisers
- Dr John Lloyd, Partner, Edwards Wildman Innovations
LLP - Gustavo de Freitas Morais, Partner, Dannemann Siemsen
Advogados - Christian Dierks, Founder and Senior Partner, Dierks +
Bohle; Professor for Health Services Research, Charité
Berlin - Prof. Burkhard Sträter, Senior and Founding Partner,
Sträter Rechtsanwälte - Dr. Thomas Bopp, Associated Partner, Gleiss Lutz Rechtsanwälte
- Dr. Henrik Holzapfel, Associated Partner, Gleiss Lutz
Rechtsanwälte - Dr. Anna Wolters, Senior European Consultant, Bird &
Bird LLP - Bert Oosting, Partner, Hogan Lovells LLP
- Steffen Steininger, Partner, Hogan Lovells LLP
- Bart Swinkels, EPA,Partner, Nederlandsch Octooibureau
- Dr. Penny Gilbert, Partner, Powell Gilbert LLP
- Christopher Stothers, Partner, Arnold Porter (UK) LLP
"Excellent conference, informative. Professional organisation."
O Swens
"Excellent choice of speakers"
Past delegate, EPO
Key reasons to attend IBC Legal Conferences' Biotech & Pharmaceutical Patenting 2012 event in Munich
- Analyse the evolving biotech & pharmaceutical case law and recent developments in Europe and the US
- Maximise your chance of successful patent filing for new scientific processes with a coal face look at trends in patent protection strategies and competative patent filing
- Optimise your patent life cycles and extend your market dominance
- Examine SPCs in our tailored masterclass analysing the implications of the most recent and relevant cases
- Hear in-depth insights on the legal procedures for avoiding patent infringement in clinical trials and the EC Bolar implementation
- Learn from a legal adviser speaker faculty comprised of 7 of the top three bands in Chambers & Partners!
Just some of the companies that have attended this essential update event!
Philip Morris Products - BioGeneriX -Transgene -Fujifilm -Clavis Pharma -Merck Serono -Teva Pharmaceutical Industry -Warner Chilcott UK -Oxford Immunotec -Synthon -Int'l Patent Bureau -Genepharm -IMS Health -DSM Nutritional Products -Sanofi Pasteur -Astrazeneca R&D -Actelion Pharmaceuticals -Institut Francais Du Petrole -Ivax Pharmaceuticals -F Hoffmann-La Roche -Micromet -Helsinn Healthcare -Fibrogen Inc -United Trademark & Patent Services -Robert Bosch -Philips -Novozymes -Pliva Research Institute -British American Tobacco Investments -Unipath -Merial -Novo Nordisk -Saudi Food & Drug Authority -Bioinvent Int'l -Nony & Partners -Howrey -Solvay Pharmaceuticals -Sagem Defense Securite -Novartis Pharma -Zacco Norway -Cambridge Antibody Technology -Norwegian Industrial Property Office -Innate Pharma -Al-Hikma Pharmaceuticals -Pfizer
Associate Sponsors:
Media Partners:
Feeds | Like | Share    |
Download Latest Information Now
(updated 19 May 2012)
What do your peers think of Biotech & Pharmaceutical Patenting?
"All you need to know in biotech and pharma: annual update!"
